Novel malaria drug clears parasitemia in phase 2 study
1. KAE609, a novel spiroindolone class drug, was shown to have rapid antimalarial activity in this phase 2, open-label trial ...
Tag: KAE609
1. KAE609, a novel spiroindolone class drug, was shown to have rapid antimalarial activity in this phase 2, open-label trial ...